Canada’s Restaurant Brands Announces Mixed Financial Results
Restaurant Brands International (QSR), the parent company of Tim Hortons, has reported mixed financial results for this year’s second quarter. The Toronto-based company, which reports in U.S. dollars, announced earnings per share (EPS) of $0.94 U.S., which was below the $0.97 U.S. that was expected among analysts.Revenue in the April through June period of $2.41 billion U.S. came in ahead of expectations for $2.32 billion U.S. Sales were up 16% from a year ago.Management said the mixed results were due to a same-store sales decline at its Popeyes restaurant chain, which was partially offset by strong international sales at Tim Hortons.The company’s overall same-store sales, which track restaurants open at least a year, rose 2.4% during the quarter. International restaurants reported same-store sales growth of 4.2%.Tim Hortons, which accounts for more than 40% of Restaurant Brands’ revenue, reported same-store sales growth of 3.4% during the quarter.Burger King reported same-store sales growth of 1.3%. Its U.S. division, which has been in a turnaround for nearly three years, saw same-store sales increase by 1.5%.Popeyes was the laggard of the company’s restaurant chains, posting a same-store sales decline of 1.4% in Q2.Looking ahead, Restaurant Brands reiterated its previous forecast that calls for 3% same-store sales growth and 8% operating income growth between 2024 and 2028.The company plans to spend between $400 million U.S. and $450 million U.S. in capital expenditures this year. QSR stock has gained 5% this year to trade at $68.60 U.S. per share in New York.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


